Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 30

Sort by

Sort Order Select

Journal Articles

Characteristics of Marijuana Usage in Sickle Cell Patients: A Nationwide Analysis

Arya Mariam Roy, MD, Manojna Konda, MD, Akshay Goel, MD, Appalanaidu Sasapu, MD

Blood (2019) 134 (Supplement_1): 4848.

https://doi.org/10.1182/blood-2019-131489

Published: 2019

Journal Articles

Effect of Marijuana Smoking Among Adult Sickle Cell Patients on Trends in Sickle Cell Crisis Hospitalizations and Acute Chest Syndrome: A Nationwide Inpatient Assessment

Shashank Sama, MBBS, Varun Tandon, Nikhila Kethireddy, Prajwal Boddu, MD

Blood (2019) 134 (Supplement_1): 4850.

https://doi.org/10.1182/blood-2019-122179

Published: 2019

Journal Articles

Cannabidiol Reduces Acute and Chronic Hyperalgesia in Humanized Sickle Mice

Varun Sagi, BS, Jianxun Lei, PhD, Stacy B Kiven, BS, Huy Tran, BS, Kalpna Gupta, PhD

Blood (2019) 134 (Supplement_1): 77.

https://doi.org/10.1182/blood-2019-129706

Published: 2019

Journal Articles

A Clinical Trial of Cannabis As Targeted Therapy for Indolent Leukemic Lymphoma

Christopher M Melén, MD, Magali Merrien, MSc, Agata Wasik, MSc, PhD, Kristina Sonnevi, MD PhD, Henna-Riikka Junlén, MD, Birger Christersson, MD PhD, Birgitta Sander, MD PhD Prof., Björn E Wahlin, MD PhD

Blood (2019) 134 (Supplement_1): 5487.

https://doi.org/10.1182/blood-2019-126693

Published: 2019

Journal Articles

A Case Report of the Benefit of Cannabidiol (Cannabidiol (CBD)-Predominant Medical Cannabis Preparation) in the Management of Refractory Skin Graft Vs Host Disease (GVHD)

Tsiporah B. Shore, MD, Jessy B. Ryan, ANP, Michael B. Samuel, MD

Blood (2019) 134 (Supplement_1): 5687.

https://doi.org/10.1182/blood-2019-122715

Published: 2019

Journal Articles

Clinical Characteristics and Health Care Utilization Patterns of Sickle Cell Disease Patients Using Marijuana

Hope Miodownik, BA, Christopher Bradford, BA, Joanna L. Starrels, MD MS, Ugochi Olivia Ogu, MD, Merin Thomas, NP, Chinazo O. Cunningham, MD MS, Julia H. Arnsten, MD MPH, Caterina Minniti, MD

Blood (2018) 132 (Supplement 1): 3669.

https://doi.org/10.1182/blood-2018-99-118163

Published: 2018

Journal Articles

Medical Marijuana Certification for Patients with Sickle Cell Disease: A Survey Study of Patient's Use and Preferences

Susanna A Curtis, MD, Jonathan Spodick, MA, LCSW, Dana Lew, BS, John D. Roberts, MD

Blood (2018) 132 (Supplement 1): 1094.

https://doi.org/10.1182/blood-2018-99-118345

Published: 2018

Journal Articles

Relationship between Non-Prescribed Drug Use and Employment Status of Patients with Sickle Cell Disease

Modupe Idowu, MD, Tong Han Chung, PhD, Katherine Yu

Blood (2018) 132 (Supplement 1): 4932.

https://doi.org/10.1182/blood-2018-99-120373

Published: 2018

Journal Articles

Medical Marijuana for Sickle Cell Disease: Results of Two Years of Certification in an Adult Sickle Cell Center

Susanna A Curtis, MD, Dana Lew, BS, Jonathan Spodick, MA, LCSW, John D. Roberts, MD

Blood (2018) 132 (Supplement 1): 858.

https://doi.org/10.1182/blood-2018-99-118290

Published: 2018

Journal Articles

Evaluation of Safety, Efficacy, and Clinical Endpoints of Delta-9-Tetrahydrocannabinol in Patients Age 60 or Older with Hematologic and Oncologic Malignancies

Damien Hansra, MD, Hugo Granada, MD

Blood (2017) 130 (Supplement 1): 5672.

https://doi.org/10.1182/blood.V130.Suppl_1.5672.5672

Published: 2017

Journal Articles

Daily Users of Marijuana with Sickle Cell Disease Report More Severe Pain Crisis Yet Have Similar Rates of Admission to Non-Users

Susanna A Curtis, MD, Michelle Deveaux, Daniel Zelterman, Lesley Devine, PhD, Amanda M Brandow, DO, MS, John D. Roberts, MD

Blood (2017) 130 (Supplement 1): 3559.

https://doi.org/10.1182/blood.V130.Suppl_1.3559.3559

Published: 2017

Journal Articles

Pain in the Bleeding Disorders Community: Patient and Caregiver Perspectives

Tyler W. Buckner, MD MSc, Nancy Durben, PT, MSPT, PCS, Christi Humphrey, LCSW, Eric Iglewski, LMSW, Jennifer Newman, MSPT, Maria E Santaella, RN-BC, MSN, CPHON, Michelle Witkop, DNP, FNP-BC

Blood (2016) 128 (22): 2591.

https://doi.org/10.1182/blood.V128.22.2591.2591

Published: 2016

Journal Articles

The Use of Marijuana and Hydroxyurea Among Sickle Cell Patients

Nene Kalu, LGSW, Patricia A. O'Neal, MD, Catherine Nwokolo, RN, Sharmin Diaz, FNP, Oluwakemi Owoyemi, MD MPH

Blood (2016) 128 (22): 5913.

https://doi.org/10.1182/blood.V128.22.5913.5913

Published: 2016

Journal Articles

Use of Marijuana in Patients with Sickle Cell Disease Increased the Frequency of Hospitalization for Acute Painful Vaso-Occlusive Crises

Samir K. Ballas, MD

Blood (2016) 128 (22): 2498.

https://doi.org/10.1182/blood.V128.22.2498.2498

Published: 2016

Journal Articles

Cannabinoid Receptor Signaling As a Target for Personalized Therapy in Aggressive B Cell Lymphomas

Lan Pham, PhD, Juan Chen, PhD, Archie Tamayo, MS, Jerry Bryant, David Yang, PhD, Richard J. Ford, Jr., MD PhD

Blood (2016) 128 (22): 4181.

https://doi.org/10.1182/blood.V128.22.4181.4181

Published: 2016

Journal Articles

Multi-Institution Review of Adult Early T-Cell Precursor Acute Lymphoblastic Leukemia/Lymphoma (ETP-ALL)

Bijal D. Shah, MD, Uma Borate, MD, Vamsi K Kota, MD, Ling Zhang, MD, Deniz Peker, MD, Amanda Redden Hathaway, MD, Julio C Chavez, MD

Blood (2015) 126 (23): 3715.

https://doi.org/10.1182/blood.V126.23.3715.3715

Published: 2015

Journal Articles

Cannabinoids As Antimyeloma Agents: a New Approach for the Treatment of Multiple Myeloma

María Victoria Barbado, PhD, Mayte Medrano, Jose Ignacio Piruat, PhD, Ivan Valle, Teresa Caballero, PhD, Isabel Álvarez, Jose Antonio Perez-Simón, MDPhD

Blood (2014) 124 (21): 4724.

https://doi.org/10.1182/blood.V124.21.4724.4724

Published: 2014

Journal Articles

Cannabidiol - An Innovative Strategy For Graft Versus Host Disease Prevention

Moshe Yeshurun, MD, Ofer Shpilberg, MD, MPH, Corina Herscovici, MD, Juliet Dreyer, RN, Anat Peck, RN, Maly Levy Assaraf, PhD, Tsipora Gruenewald, M.Ph.Sc, Raphael Mechoulam, PhD, Ron Ram, MD

Blood (2013) 122 (21): 3299.

https://doi.org/10.1182/blood.V122.21.3299.3299

Published: 2013

Journal Articles

Cannabinoid Receptor 1 in Chronic Lymphocytic Leukemia: Strong Prognostic Marker with Limited Therapeutic Use

Patricia Weiss, Edit Anna Porpaczy, MD, Trang Le, Cathrin Skrabs, Michaela Gruber, Clemens Pausz, Ulrich Jäger, Katrina Vanura

Blood (2012) 120 (21): 4565.

https://doi.org/10.1182/blood.V120.21.4565.4565

Published: 2012

Journal Articles

Gynecomastia In Multiple Myeloma Patient Treated with Cytoxan

Ahmad Jajeh, MD, MPH

Blood (2011) 118 (21): 5131.

https://doi.org/10.1182/blood.V118.21.5131.5131

Published: 2011

NARROW

Characteristics of Marijuana Usage in Sickle Cell Patients: A Nationwide Analysis

Effect of Marijuana Smoking Among Adult Sickle Cell Patients on Trends in Sickle Cell Crisis Hospitalizations and Acute Chest Syndrome: A Nationwide Inpatient Assessment

Cannabidiol Reduces Acute and Chronic Hyperalgesia in Humanized Sickle Mice

A Clinical Trial of Cannabis As Targeted Therapy for Indolent Leukemic Lymphoma

A Case Report of the Benefit of Cannabidiol (Cannabidiol (CBD)-Predominant Medical Cannabis Preparation) in the Management of Refractory Skin Graft Vs Host Disease (GVHD)

Clinical Characteristics and Health Care Utilization Patterns of Sickle Cell Disease Patients Using Marijuana

Medical Marijuana Certification for Patients with Sickle Cell Disease: A Survey Study of Patient's Use and Preferences

Relationship between Non-Prescribed Drug Use and Employment Status of Patients with Sickle Cell Disease

Medical Marijuana for Sickle Cell Disease: Results of Two Years of Certification in an Adult Sickle Cell Center

Evaluation of Safety, Efficacy, and Clinical Endpoints of Delta-9-Tetrahydrocannabinol in Patients Age 60 or Older with Hematologic and Oncologic Malignancies

Daily Users of Marijuana with Sickle Cell Disease Report More Severe Pain Crisis Yet Have Similar Rates of Admission to Non-Users

Pain in the Bleeding Disorders Community: Patient and Caregiver Perspectives

The Use of Marijuana and Hydroxyurea Among Sickle Cell Patients

Use of Marijuana in Patients with Sickle Cell Disease Increased the Frequency of Hospitalization for Acute Painful Vaso-Occlusive Crises

Cannabinoid Receptor Signaling As a Target for Personalized Therapy in Aggressive B Cell Lymphomas

Multi-Institution Review of Adult Early T-Cell Precursor Acute Lymphoblastic Leukemia/Lymphoma (ETP-ALL)

Cannabinoids As Antimyeloma Agents: a New Approach for the Treatment of Multiple Myeloma

Cannabidiol - An Innovative Strategy For Graft Versus Host Disease Prevention

Cannabinoid Receptor 1 in Chronic Lymphocytic Leukemia: Strong Prognostic Marker with Limited Therapeutic Use

Gynecomastia In Multiple Myeloma Patient Treated with Cytoxan

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only